mavacoxib mavacoxib mavacoxib (trade name trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease. it acts as a cox-2 inhibitor. mavacoxibclinical datatrade namestrocoxilahfs/drugs.cominternational drug namesatcvet codeqm01ah92 (who) identifierscas number170569-88-7pubchem cid9843089chemspider8018804uniiyft7x7sr77chebichebi:76207comptox dashboard (epa)dtxsid90168880 echa infocard100.248.948 chemical and physical dataformulac16h11f4n3o2smolar mass385.34 g·mol−13d model (jsmol)interactive image smiles c1=cc(=cc=c1c2=cc(=nn2c3=cc=c(c=c3)s(=o)(=o)n)c(f)(f)f)f inchi inchi=1s/c16h11f4n3o2s/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9h,(h2,21,24,25)key:ttznqdounxbmjv-uhfffaoysa-n mavacoxib, along with other cox-2 selective inhibitors, celecoxib, valdecoxib, and parecoxib, were discovered by a team at the searle division of monsanto led by john talley.